R. GÜLHAN Et Al. , "Pharmacokinetic characterization of favipiravir in patients with COVID-19," BRITISH JOURNAL OF CLINICAL PHARMACOLOGY , vol.88, no.7, pp.3516-3522, 2022
GÜLHAN, R. Et Al. 2022. Pharmacokinetic characterization of favipiravir in patients with COVID-19. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY , vol.88, no.7 , 3516-3522.
GÜLHAN, R., Eryuksel, E., Oglu, M. G. I., Culpan, Y., Toplu, A., KOCAKAYA, D., ... TİGEN, E.(2022). Pharmacokinetic characterization of favipiravir in patients with COVID-19. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY , vol.88, no.7, 3516-3522.
GÜLHAN, REZZAN Et Al. "Pharmacokinetic characterization of favipiravir in patients with COVID-19," BRITISH JOURNAL OF CLINICAL PHARMACOLOGY , vol.88, no.7, 3516-3522, 2022
GÜLHAN, REZZAN Et Al. "Pharmacokinetic characterization of favipiravir in patients with COVID-19." BRITISH JOURNAL OF CLINICAL PHARMACOLOGY , vol.88, no.7, pp.3516-3522, 2022
GÜLHAN, R. Et Al. (2022) . "Pharmacokinetic characterization of favipiravir in patients with COVID-19." BRITISH JOURNAL OF CLINICAL PHARMACOLOGY , vol.88, no.7, pp.3516-3522.
@article{article, author={REZZAN GÜLHAN Et Al. }, title={Pharmacokinetic characterization of favipiravir in patients with COVID-19}, journal={BRITISH JOURNAL OF CLINICAL PHARMACOLOGY}, year=2022, pages={3516-3522} }